GENI holder plans Rule 144 sale of 9,414 NYSE common shares

GENI shareholder filed a Rule 144 notice for the proposed sale of 9,414 common shares.

Rhea-AI Filing Summary

GENI shareholder filed a Rule 144 notice for the proposed sale of 9,414 common shares. The shares were acquired on 12/12/2025 through restricted stock vesting as compensation from the issuer and are planned to be sold through Fidelity Brokerage Services LLC on the NYSE around 12/15/2025, with an aggregate market value of $100,750.51. The issuer reported 214,097,454 common shares outstanding, giving context for the size of this planned transaction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the GENI Rule 144 filing disclose?

It discloses that a GENI shareholder filed a notice of proposed sale for 9,414 common shares under Rule 144, to be executed through a broker on the NYSE.

How many GENI shares are planned to be sold and what is the market value?

The notice covers a proposed sale of 9,414 GENI common shares with an aggregate market value of $100,750.51.

When and how were the GENI shares to be sold acquired?

The GENI shares were acquired on 12/12/2025 via Restricted Stock Vesting from the issuer as compensation.

What is the approximate date and venue for the GENI share sale?

The approximate date of sale is 12/15/2025, with trading to occur on the NYSE through Fidelity Brokerage Services LLC.

How many GENI shares are outstanding according to the notice?

The notice states that there are 214,097,454 GENI common shares outstanding, providing context for the relative size of the proposed sale.

What type of GENI security is covered by this Rule 144 notice?

The filing relates to GENI common shares listed for trading on the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/15/2025 - 03:47 PM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002012006
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Genius Sports Ltd
SEC File Number	001-40352
Address of Issuer	27 SOHO SQUARE, 1ST FLOOR GENIUS SPORTS GROUP LONDON UNITED KINGDOM W1D 3QR
Phone	44 (0) 20 7851 4060
Name of Person for Whose Account the Securities are To Be Sold	Burns Daniel Paul
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	9414	100750.51	214097454	12/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/12/2025	Restricted Stock Vesting	Issuer			9414	12/12/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	12/15/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Daniel Burns
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)